RT Journal Article
SR Electronic
T1 837 Combination treatment with ATOR-4066, a Neo-X-Prime™ bispecific antibody targeting CD40 and CEACAM5, and anti-PD-1 reverses T cell exhaustion in vitro
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A935
OP A935
DO 10.1136/jitc-2023-SITC2023.0837
VO 11
IS Suppl 1
A1 Uddbäck, Ida
A1 Fritzell, Sara
A1 Ljung, Lill
A1 Nilsson, Anneli
A1 Celander, Mona
A1 Shetty, Amulya Krishna
A1 Andersson, Hampus
A1 Jimenez, David Gomez
A1 Levin, Mattias
A1 Lindstedt, Malin
A1 Hägerbrand, Karin
A1 Sundstedt, Anette
A1 Ellmark, Peter
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A935.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.